down arrow

Biosino Bio-Technology & Science, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000288
HKD
3.04
-0.13 (-4.26%)

Sep 23

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Biosino Bio-Technology & Science, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-73.00
-64.00
-33.00
13.00
5.00
0.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
4.00
36.00
-3.00
2.00
-6.00
-6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-33.00
18.00
-13.00
44.00
46.00
13.00
Cash Flow from Investing Activities
-3.00
-14.00
-1.00
-1.00
-7.00
-29.00
Cash Flow from Financing Activities
9.00
1.00
0.00
-5.00
-40.00
34.00
Net Cash Inflow / Outflow
-26.00
5.00
-15.00
38.00
-1.00
17.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Biosino Bio-Technology & Science, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-73.0361418779445
6.842
-79.00
-1167.47%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
4.78491711162822
-32.824
36.00
114.58%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-33.0193985450211
-13.357
-20.00
-147.21%
Cash Flow from Investing Activities
-3.26116177576294
0
-3.00
0.00%
Cash Flow from Financing Activities
9.5720032699979
-0.614
9.00
1658.96%
Net Cash Inflow / Outflow
-26.7801355932538
0.222
-26.00
-12163.12%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.0715785424676933
14.193
-14.00
-100.50%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -280.94% vs 238.14% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-33.02
18.25
-280.94%

Footer loading